Harbin Pharmaceutical Group Co., Ltd.SSE: 600664

Announcement on "Corporate Value and Return Enhancement" Action Plan 2025

· Issued by Harbin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 4 pages · Chinese

Release

Announcement on "Corporate Value and Return Enhancement" Action Plan 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Harbin Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Harbin Pharmaceutical

Later from Harbin Pharmaceutical

All Harbin Pharmaceutical news releases